Technical Analysis for ARAV - Aravive, Inc.

Grade Last Price % Change Price Change
grade C 12.53 -2.03% -0.26
ARAV closed down 2.03 percent on Friday, January 17, 2020, on 20 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical ARAV trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Fell Below 20 DMA Bearish -2.03%
NR7 Range Contraction -7.32%
NR7-2 Range Contraction -7.32%
Up 3 Days in a Row Strength -7.32%
20 DMA Support Bullish -5.79%
NR7 Range Contraction -5.79%
20 DMA Support Bullish -4.93%
20 DMA Support Bullish -4.42%
Up 3 Days in a Row Strength -9.01%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Aravive, Inc., a clinical stage biotechnology company, focuses on developing therapies for solid tumors and hematologic malignancies. It is developing AVB-S6-500, a GAS6 binding protein and AXL decoy receptor, for the treatment of ovarian cancer, as well as for renal cell carcinoma, acute myeloid leukemia, triple negative breast cancer and pancreatic cancer. The company was formerly known as Versartis, Inc. and changed its name to Aravive, Inc. in October 2018. Aravive, Inc. is based in Houston, Texas.
Biotechnology Cancer Solid Tumors Acute Myeloid Leukemia Ovarian Cancer Cell Biology Pancreatic Cancer Hematologic Malignancies Bemcentinib Renal Cell Carcinoma Treatment Of Ovarian Cancer Triple Negative Breast Cancer

Is ARAV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.62
52 Week Low 3.22
Average Volume 644,642
200-Day Moving Average 7.47
50-Day Moving Average 11.01
20-Day Moving Average 13.06
10-Day Moving Average 13.18
Average True Range 0.93
ADX 27.23
+DI 23.87
-DI 19.94
Chandelier Exit (Long, 3 ATRs ) 11.78
Chandelier Exit (Short, 3 ATRs ) 13.96
Upper Bollinger Band 14.34
Lower Bollinger Band 11.78
Percent B (%b) 0.29
BandWidth 19.61
MACD Line 0.48
MACD Signal Line 0.71
MACD Histogram -0.225
Fundamentals Value
Market Cap 445.8 Million
Num Shares 35.6 Million
EPS -3.45
Price-to-Earnings (P/E) Ratio -3.63
Price-to-Sales 0.00
Price-to-Book 0.86
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.46
Resistance 3 (R3) 13.56 13.36 13.31
Resistance 2 (R2) 13.36 13.12 13.31 13.25
Resistance 1 (R1) 12.94 12.97 12.84 12.84 13.20
Pivot Point 12.74 12.74 12.69 12.69 12.74
Support 1 (S1) 12.32 12.50 12.22 12.22 11.86
Support 2 (S2) 12.12 12.35 12.07 11.81
Support 3 (S3) 11.70 12.12 11.76
Support 4 (S4) 11.60